Literature DB >> 7504541

Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukemia.

I Brodsky1, B Foley, D Gillespie.   

Abstract

We have previously demonstrated the presence of a reverse transcriptase-like enzyme in retroviral particles from patients with essential thrombocythemia, polycythemia vera, and chronic myelogenous leukemia. It was subsequently shown that the human genome contains 50 copies of HERV-K. HERV-K is a human endogenous class I retroviral element that contains gag, pol, and env open reading frames. Using both reverse transcriptase-polymerase chain reaction and ribonuclease protection assays, it is demonstrated that the HERV-K pol is expressed in human blood leukocytes. The data indicates that this expression is restricted in CML white cells and is the result of gene regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504541     DOI: 10.3109/10428199309047874

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

1.  Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers.

Authors:  Tiffany A Wallace; Ronan F Downey; Caleb J Seufert; Aaron Schetter; Tiffany H Dorsey; Carol A Johnson; Radoslav Goldman; Christopher A Loffredo; Peisha Yan; Francis J Sullivan; Francis J Giles; Feng Wang-Johanning; Stefan Ambs; Sharon A Glynn
Journal:  Carcinogenesis       Date:  2014-05-23       Impact factor: 4.944

2.  The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3' to the TATA box.

Authors:  E Sjøttem; S Anderssen; T Johansen
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

3.  Genomic flexibility of human endogenous retrovirus type K.

Authors:  Derek Dube; Rafael Contreras-Galindo; Shirley He; Steven R King; Marta J Gonzalez-Hernandez; Scott D Gitlin; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice.

Authors:  A E Casau; J E Vaughan; G Lozano; A J Levine
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Human endogenous retrovirus W env increases nitric oxide production and enhances the migration ability of microglia by regulating the expression of inducible nitric oxide synthase.

Authors:  Ran Xiao; Shan Li; Qian Cao; Xiuling Wang; Qiujin Yan; Xiaoning Tu; Ying Zhu; Fan Zhu
Journal:  Virol Sin       Date:  2017-06-23       Impact factor: 4.327

6.  Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues.

Authors:  A Willer; S Saussele; W Gimbel; W Seifarth; P Kister; C Leib-Mösch; R Hehlmann
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

7.  Distribution of human endogenous retrovirus HERV-K genomes in humans and different primates.

Authors:  S Steinhuber; M Brack; G Hunsmann; H Schwelberger; M P Dierich; W Vogetseder
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

8.  Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia.

Authors:  G Bogdanovic; C Pou; M Barrientos-Somarribas; A Bjerkner; E Honkaniemi; T Allander; B Andersson; B Gustafsson
Journal:  Br J Cancer       Date:  2016-08-23       Impact factor: 7.640

Review 9.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

10.  Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival.

Authors:  Maria Giebler; Martin S Staege; Sindy Blauschmidt; Lea I Ohm; Matthias Kraus; Peter Würl; Helge Taubert; Thomas Greither
Journal:  Front Microbiol       Date:  2018-02-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.